COVID-19 BioKit IgG/IgM
COVID-19 BioKit IgG/IgM is a lateral flow chromatographic immunoassay kit, intended for the qualitative detection of IgM and IgG against SARS-CoV-2 in blood, serum, fingerstick or venous blood from patients suspected of COVID-19 infection.
MFDS
Key Characteristics
| Easy-to-use |
No lab-based instruments needed |
|---|---|
| Accurate |
Sensitivity : Above 91% * Specificity : Above 99% * |
| Rapid results |
Delivers results in just 15-20 minutes |
| Shelf life |
24 months |
* Clinical sensitivity and specificity obtained from the clinical trial completed on the June 25th, 2021.